Wenyan Miao

2.3k total citations
26 papers, 1.3k citations indexed

About

Wenyan Miao is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Wenyan Miao has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Wenyan Miao's work include Chemokine receptors and signaling (5 papers), Immunotherapy and Immune Responses (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Wenyan Miao is often cited by papers focused on Chemokine receptors and signaling (5 papers), Immunotherapy and Immune Responses (5 papers) and Cytokine Signaling Pathways and Interactions (5 papers). Wenyan Miao collaborates with scholars based in United States, Austria and Singapore. Wenyan Miao's co-authors include Mark S. Marshall, Darlene Barnard, Alastair J. King, Huaiyu Sun, Shubha Bagrodia, Bruce Diaz, William Westlin, Rosana Kapeller, Amy E. Lin and Guri Tzivion and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Wenyan Miao

25 papers receiving 1.3k citations

Peers

Wenyan Miao

IMMUN

ONCOL

PFM

Valeria Berno Italy

Céline Charvet France

James Tunstead United States

Kathryn Hadfield United Kingdom

Rosana Meyer United States

Gabriela Schneider United States

S Krajewski United States

Svetlana A. Didichenko Switzerland

Xiu-Rong Ren United States

Aleata A. Triplett United States

Valeria Berno Italy

Wenyan Miao

797 ×1.1

155 ×0.5

IMMUN

236 ×0.8

ONCOL

94 ×0.6

112 ×0.9

PFM

Citations per year, relative to Wenyan Miao Wenyan Miao (= 1×) peers Valeria Berno

Countries citing papers authored by Wenyan Miao

Since Specialization

Citations

This map shows the geographic impact of Wenyan Miao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyan Miao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyan Miao more than expected).

Fields of papers citing papers by Wenyan Miao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyan Miao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyan Miao. The network helps show where Wenyan Miao may publish in the future.

Co-authorship network of co-authors of Wenyan Miao

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyan Miao. A scholar is included among the top collaborators of Wenyan Miao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyan Miao. Wenyan Miao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Hua, et al.. (2024). Subcellular location of L1 retrotransposon-encoded ORF1p, reverse transcription products, and DNA sensors in lupus granulocytes. Mobile DNA. 15(1). 14–14. 3 indexed citations

Miao, Wenyan, Ying Liu, Gang Chen, et al.. (2023). Unique Reduced-Intensity Conditioning Haploidentical Peripheral Blood Stem Cell Transplantation Protocol for Patients with Hematologic Malignancy. Transplantation and Cellular Therapy. 29(5). 331.e1–331.e8.

Leit, Silvana, Jeremy R. Greenwood, Sayan Mondal, et al.. (2022). Potent and selective TYK2-JH1 inhibitors highly efficacious in rodent model of psoriasis. Bioorganic & Medicinal Chemistry Letters. 73. 128891–128891. 10 indexed citations

Gracey, Eric, Melissa Lim, Zoya Qaiyum, et al.. (2020). TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis. Journal of Clinical Investigation. 130(4). 1863–1878. 54 indexed citations

Improgo, Ma. Reina, Bethany Tesar, Josephine L. Klitgaard, et al.. (2018). MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL. British Journal of Haematology. 184(6). 925–936. 15 indexed citations

Akahane, Koshi, Zhaodong Li, Julia Etchin, et al.. (2017). Anti‐leukaemic activity of the TYK2 selective inhibitor NDI‐031301 in T‐cell acute lymphoblastic leukaemia. British Journal of Haematology. 177(2). 271–282. 28 indexed citations

Masse, C. E., Wenyan Miao, Jeremy R. Greenwood, et al.. (2015). Identification of highly potent and selective Tyk2 inhibitors for the treatment of autoimmune diseases through structure-based drug design (THER2P.961). The Journal of Immunology. 194(1_Supplement). 67.12–67.12. 3 indexed citations

Bieszczad, Kasia M., James R. Rusche, Vincent Jacques, et al.. (2015). Histone Deacetylase Inhibition via RGFP966 Releases the Brakes on Sensory Cortical Plasticity and the Specificity of Memory Formation. Journal of Neuroscience. 35(38). 13124–13132. 57 indexed citations

Kelly, Priscilla N., Donna L. Romero, Yibin Yang, et al.. (2015). Selective interleukin-1 receptor–associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy. The Journal of Experimental Medicine. 212(13). 2189–2201. 128 indexed citations

10.

Matthews, Geoffrey M., Leonie A. Cluse, Eric Wang, et al.. (2014). Abstract 5533: RNAi-mediated depletion of histone deacetylases highlights the potential for isoform-specific inhibitors in B-cell lymphoma and acute myeloid leukemia. Cancer Research. 74(19_Supplement). 5533–5533. 1 indexed citations

11.

Brodfuehrer, Joanne, Andrew L. Rankin, Jason Edmonds, et al.. (2013). Quantitative Analysis of Target Coverage and Germinal Center Response by a CXCL13 Neutralizing Antibody in a T-Dependent Mouse Immunization Model. Pharmaceutical Research. 31(3). 635–648. 17 indexed citations

12.

Plasterer, Heather L., Wenyan Miao, Zhihua Feng, et al.. (2013). The DcpS inhibitor RG3039 improves motor function in SMA mice. Human Molecular Genetics. 22(20). 4074–4083. 50 indexed citations

13.

Bloom, Laird, et al.. (2010). A Human CXCL13-Induced Actin Polymerization Assay Measured by Fluorescence Plate Reader. Assay and Drug Development Technologies. 8(1). 73–84. 3 indexed citations

14.

Breinlinger, Eric C., Grier A. Wallace, Wenyan Miao, et al.. (2008). Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3. Bioorganic & Medicinal Chemistry Letters. 18(7). 2414–2419. 13 indexed citations

15.

Wallace, Grier A., Wenyan Miao, Michael J. McPherson, et al.. (2008). Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3. Bioorganic & Medicinal Chemistry Letters. 18(5). 1573–1576. 30 indexed citations

16.

Marsilje, Thomas H., Stephen G. Stroud, Christopher Blackburn, et al.. (2004). Synthesis and biological evaluation of imidazole-based small molecule antagonists of the melanocortin 4 receptor (MC4-R). Bioorganic & Medicinal Chemistry Letters. 14(14). 3721–3725. 27 indexed citations

17.

Yip-Schneider, Michele, Wenyan Miao, Amy E. Lin, et al.. (2000). Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association. Biochemical Journal. 351(1). 151–151. 74 indexed citations

18.

King, Alastair J., Huaiyu Sun, Bruce Diaz, et al.. (1998). The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature. 396(6707). 180–183. 363 indexed citations

19.

Miao, Wenyan, et al.. (1996). p120 Ras GTPase-activating Protein Interacts with Ras-GTP through Specific Conserved Residues. Journal of Biological Chemistry. 271(26). 15322–15329. 29 indexed citations

20.

Mitchell, Anna L., et al.. (1996). N-terminal Sequences Contained in the Src Homology 2 and 3 Domains of p120 GTPase-activating Protein Are Required for Full Catalytic Activity Toward Ras. Journal of Biological Chemistry. 271(9). 5195–5199. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact